Literature DB >> 18092818

Comparison of the structural properties of the active site cavities of human and rat monoamine oxidase A and B in their soluble and membrane-bound forms.

Anup K Upadhyay1, Jin Wang, Dale E Edmondson.   

Abstract

Structural properties of the active site cavities in human and rat monoamine oxidases (MAOA and MAOB) have been studied in their detergent-purified and outer mitochondrial membrane (OMM) bound forms using a spin-labeled irreversible inhibitor (ParSL) as an active specific spin probe. ParSL has been found to be 5-10-fold more specific for human MAOB (hMAOB) with a Ki of ca. 20 muM, compared to Ki's in the range of 100-200 muM observed for other human and rat MAOs. Solvent accessibilities of the active-site-bound spin probes have been determined by studying the power saturation properties of the spin probe EPR signals in the presence and absence of a polar paramagnetic reagent NiEDDA and by measuring the extent of spin probe reductions on treatment with excess ascorbic acid. Results presented here show that the spin probe bound to the hMAOA active site is ca. 7-8-fold more accessible than in hMAOB. In contrast, the spin probes covalently attached to the two rat enzyme active sites show comparable accessibilities to each other. On comparison of human versus rat enzymes, the active-site-bound spin probes in the two rat MAOs show ca. 40% less accessibilities compared to the same in hMAOA but ca. 4-5-fold higher accessibilities than in hMAOB active site. The present data thus suggests that the structural properties of the active site cavities in rat MAOs are significantly different compared to those in the two human enzymes, which correlates with the differences reported earlier in the inhibitor specificities between human and rat MAOs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18092818     DOI: 10.1021/bi7019707

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

Review 1.  Molecular and mechanistic properties of the membrane-bound mitochondrial monoamine oxidases.

Authors:  Dale E Edmondson; Claudia Binda; Jin Wang; Anup K Upadhyay; Andrea Mattevi
Journal:  Biochemistry       Date:  2009-05-26       Impact factor: 3.162

2.  ²H kinetic isotope effects and pH dependence of catalysis as mechanistic probes of rat monoamine oxidase A: comparisons with the human enzyme.

Authors:  Jin Wang; Dale E Edmondson
Journal:  Biochemistry       Date:  2011-08-16       Impact factor: 3.162

Review 3.  Behavioral outcomes of monoamine oxidase deficiency: preclinical and clinical evidence.

Authors:  Marco Bortolato; Jean C Shih
Journal:  Int Rev Neurobiol       Date:  2011       Impact factor: 3.230

4.  Development of spin-labeled pargyline analogues as specific inhibitors of human monoamine oxidases A and B.

Authors:  Anup K Upadhyay; Dale E Edmondson
Journal:  Biochemistry       Date:  2009-05-12       Impact factor: 3.162

5.  Characterization of detergent purified recombinant rat liver monoamine oxidase B expressed in Pichia pastoris.

Authors:  Anup K Upadhyay; Dale E Edmondson
Journal:  Protein Expr Purif       Date:  2008-03-10       Impact factor: 1.650

6.  Distribution of monoamine oxidase proteins in human brain: implications for brain imaging studies.

Authors:  Junchao Tong; Jeffrey H Meyer; Yoshiaki Furukawa; Isabelle Boileau; Li-Jan Chang; Alan A Wilson; Sylvain Houle; Stephen J Kish
Journal:  J Cereb Blood Flow Metab       Date:  2013-02-13       Impact factor: 6.200

Review 7.  Key Targets for Multi-Target Ligands Designed to Combat Neurodegeneration.

Authors:  Rona R Ramsay; Magdalena Majekova; Milagros Medina; Massimo Valoti
Journal:  Front Neurosci       Date:  2016-08-22       Impact factor: 4.677

Review 8.  Assessment of Enzyme Inhibition: A Review with Examples from the Development of Monoamine Oxidase and Cholinesterase Inhibitory Drugs.

Authors:  Rona R Ramsay; Keith F Tipton
Journal:  Molecules       Date:  2017-07-15       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.